Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
<h4>Objective</h4>Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerativ...
Guardado en:
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/356f64993bd64394bf1b45b7d3c01d4d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:356f64993bd64394bf1b45b7d3c01d4d |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:356f64993bd64394bf1b45b7d3c01d4d2021-11-18T07:15:41ZEpigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.1932-620310.1371/journal.pone.0039186https://doaj.org/article/356f64993bd64394bf1b45b7d3c01d4d2012-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22720070/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objective</h4>Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerative processes.<h4>Methods</h4>We have studied the gene expression status and the epigenetic regulation of ECS components in peripheral blood mononuclear cells (PBMCs) of subjects with late-onset AD (LOAD) and age-matched controls (CT).<h4>Results</h4>We found an increase in fatty acid amide hydrolase (faah) gene expression in LOAD subjects (2.30 ± 0.48) when compared to CT (1.00 ± 0.14; *p<0.05) and no changes in the mRNA levels of any other gene of ECS elements. Consistently, we also observed in LOAD subjects an increase in FAAH protein levels (CT: 0.75 ± 0.04; LOAD: 1.11 ± 0.15; *p<0.05) and activity (pmol/min per mg protein CT: 103.80 ± 8.73; LOAD: 125.10 ± 4.00; *p<0.05), as well as a reduction in DNA methylation at faah gene promoter (CT: 55.90 ± 4.60%; LOAD: 41.20 ± 4.90%; *p<0.05).<h4>Conclusions</h4>Present findings suggest the involvement of FAAH in the pathogenesis of AD, highlighting the importance of epigenetic mechanisms in enzyme regulation; they also point to FAAH as a new potential biomarker for AD in easily accessible peripheral cells.Claudio D'AddarioAndrea Di FrancescoBeatrice ArosioCristina GussagoBernardo Dell'OssoMonica BariDaniela GalimbertiElio ScarpiniA Carlo AltamuraDaniela MariMauro MaccarronePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 7, Iss 6, p e39186 (2012) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Claudio D'Addario Andrea Di Francesco Beatrice Arosio Cristina Gussago Bernardo Dell'Osso Monica Bari Daniela Galimberti Elio Scarpini A Carlo Altamura Daniela Mari Mauro Maccarrone Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease. |
description |
<h4>Objective</h4>Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerative processes.<h4>Methods</h4>We have studied the gene expression status and the epigenetic regulation of ECS components in peripheral blood mononuclear cells (PBMCs) of subjects with late-onset AD (LOAD) and age-matched controls (CT).<h4>Results</h4>We found an increase in fatty acid amide hydrolase (faah) gene expression in LOAD subjects (2.30 ± 0.48) when compared to CT (1.00 ± 0.14; *p<0.05) and no changes in the mRNA levels of any other gene of ECS elements. Consistently, we also observed in LOAD subjects an increase in FAAH protein levels (CT: 0.75 ± 0.04; LOAD: 1.11 ± 0.15; *p<0.05) and activity (pmol/min per mg protein CT: 103.80 ± 8.73; LOAD: 125.10 ± 4.00; *p<0.05), as well as a reduction in DNA methylation at faah gene promoter (CT: 55.90 ± 4.60%; LOAD: 41.20 ± 4.90%; *p<0.05).<h4>Conclusions</h4>Present findings suggest the involvement of FAAH in the pathogenesis of AD, highlighting the importance of epigenetic mechanisms in enzyme regulation; they also point to FAAH as a new potential biomarker for AD in easily accessible peripheral cells. |
format |
article |
author |
Claudio D'Addario Andrea Di Francesco Beatrice Arosio Cristina Gussago Bernardo Dell'Osso Monica Bari Daniela Galimberti Elio Scarpini A Carlo Altamura Daniela Mari Mauro Maccarrone |
author_facet |
Claudio D'Addario Andrea Di Francesco Beatrice Arosio Cristina Gussago Bernardo Dell'Osso Monica Bari Daniela Galimberti Elio Scarpini A Carlo Altamura Daniela Mari Mauro Maccarrone |
author_sort |
Claudio D'Addario |
title |
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease. |
title_short |
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease. |
title_full |
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease. |
title_fullStr |
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease. |
title_full_unstemmed |
Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease. |
title_sort |
epigenetic regulation of fatty acid amide hydrolase in alzheimer disease. |
publisher |
Public Library of Science (PLoS) |
publishDate |
2012 |
url |
https://doaj.org/article/356f64993bd64394bf1b45b7d3c01d4d |
work_keys_str_mv |
AT claudiodaddario epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT andreadifrancesco epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT beatricearosio epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT cristinagussago epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT bernardodellosso epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT monicabari epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT danielagalimberti epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT elioscarpini epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT acarloaltamura epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT danielamari epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease AT mauromaccarrone epigeneticregulationoffattyacidamidehydrolaseinalzheimerdisease |
_version_ |
1718423718036766720 |